McMillan Shakespeare Limited (MMS) Fair Value & Analysis
Industrials · AU · Market cap A$1.3B
Fair value as of: Jun 24, 2026
From 15 valuation models · updated 5 days ago
Share price +4.3% over the past month.
Price vs Fair Value (12 months)
12‑month range A$13.63 – A$19.56 · fair‑value band A$9.38 – A$47.58 · the A$19.24 price screens above the A$15.50 fair value. As of Jun 24, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
McMillan Shakespeare Limited (MMS) currently trades at A$19.24, while our model-based Fair Value estimate is A$15.50 — implying the stock looks roughly 19.4% overvalued today. We read business quality at 95/100 (high quality), in the Industrials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
Over the trailing twelve months, McMillan Shakespeare Limited generated revenue of A$584M at a net margin of 17.0%. Revenue grew 7.4% year over year. It earns a return on equity of 88.1%. Net debt stands at A$632M. Fundamentals as of Jun 24, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 24, 2026. TTM = trailing twelve months.
About the company
McMillan Shakespeare Limited provides salary packaging, novated leasing, disability plan management, support co-ordination, asset management, and related financial products and services in Australia and New Zealand. It operates through Group Remuneration Services, Asset Management Services, and Plan and Support Services segments. The Group Remuneration Services segment offers salary packaging and ancillary services, including novated leasing asset, motor vehicle administration, and other services. The Asset Management Services segment provides financing and ancillary management services related with motor and commercial vehicles, and equipment. The Plan and Support Services segment offers plan management and support coordination services to participants in the national disability insurance scheme. It serves federal and state governments, public and private sectors, and health and charitable organizations. The company was founded in 1988 and is headquartered in Melbourne, Australia.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
McMillan Shakespeare Limited reported revenue of A$436M in FY2025 versus A$544M in FY2021, a compound −5.4%/yr. Reported net income was A$95.3M in FY2025, compounding +11.8%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Staffing & Employment Services stocks, each showing price versus our Fair Value estimate (as of Jun 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Randstad N.V RANJY | $15.02 | $20.46 | +36% |
| Adecco Group AHEXF | $17.25 | $29.51 | +71% |
| Korn Ferry, KFY | $71.35 | $75.35 | +6% |
| Robert Half Inc RHI | $29.11 | $24.81 | -15% |
| TriNet Group TNET | $47.87 | $70.38 | +47% |
| ManpowerGroup Inc MAN | $31.33 | $23.76 | -24% |
Explore undervalued stocks
More undervalued Industrials stocks →
Frequently asked questions
Is McMillan Shakespeare Limited (MMS) undervalued?
What is the fair value of MMS?
What is the quality score of MMS?
What is the revenue of McMillan Shakespeare Limited (MMS)?
What is the net profit margin of MMS?
Does McMillan Shakespeare Limited pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.